These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 3079054

  • 1. A randomized study of cyclosporine with and without prednisone in renal allograft recipients. Canadian Transplant Group.
    MacDonald AS, Daloze P, Dandavino R, Jindal S, Bear L, Dossetor JB, Klassen J, Stiller CR, Lockwood B, Reeve CE.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1865-6. PubMed ID: 3079054
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Beneficial effect of concomitant induction with antilymphoblast globulin, cyclosporine, and steroids on long-term renal allograft outcome.
    Koga A, Moreso FJ, Seron D, Gil-Vernet S, Cruzado JM, Castelao AM, Grinyó JM.
    Transplant Proc; 2004 Jun; 36(5):1305-7. PubMed ID: 15251318
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients.
    Kuo PC, Luikart H, Busse-Henry S, Hunt SA, Valantine HA, Stinson EB, Oyer PE, Scandling JD, Alfrey EJ, Dafoe DC.
    Clin Transplant; 1995 Apr; 9(2):92-7. PubMed ID: 7599409
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection.
    Sandborn WJ, Hay JE, Porayko MK, Gores GJ, Steers JL, Krom RA, Wiesner RH.
    Hepatology; 1994 Apr; 19(4):925-32. PubMed ID: 8138267
    [Abstract] [Full Text] [Related]

  • 9. Use of antithymocyte globulin and cyclosporine to treat steroid-resistant rejection episodes in renal transplant recipients.
    Benvenisty AI, Tannenbaum GA, Cohen DJ, Appel G, Hardy MA.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1889-91. PubMed ID: 3274446
    [No Abstract] [Full Text] [Related]

  • 10. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR.
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [Abstract] [Full Text] [Related]

  • 11. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J, Masramon J, Orfila A, Cuevas X, Aubia J.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT, Deierhoi MH, Hudson S, Barber WH, Barger BO, Phillips MG, Diethelm AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR, Goldman MH, Hastillo A, Szentpetery S, Wolfgang T, Thompson J, Mohanakumar T, Katz MR, Rider S, Hanrahan J.
    J Heart Transplant; 1985 Feb; 4(4):381-4. PubMed ID: 3916511
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival.
    Bauma WD, Tang IY, Maddux MS, Veremis SA, Pollak R, Mozes MF.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1276-7. PubMed ID: 2652422
    [No Abstract] [Full Text] [Related]

  • 19. Inhibition of chronic kidney allograft rejection by cyclosporine.
    Abbud-Filho M, Ramalho HJ, Barberato JB, Corrente JE, Zerati-Filho M, Verona CB, Martucci RC, Bezas AG.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1660-2. PubMed ID: 2652544
    [No Abstract] [Full Text] [Related]

  • 20. A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporine A: preliminary results.
    Kelly JJ, Walker RG, d'Apice AJ, Kincaid-Smith P.
    Transplant Proc; 1990 Oct; 22(5):2127-8. PubMed ID: 2219318
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.